Yongsoon Park

Summary

Affiliation: Saint Luke's Hospital
Country: USA

Publications

  1. ncbi A new method for the study of chylomicron kinetics in vivo
    Y Park
    Department of Medicine, University of Missouri Kansas City, St Luke s Hospital, Kansas City, Missouri 64111, USA
    Am J Physiol Endocrinol Metab 279:E1258-63. 2000
  2. ncbi Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion
    Y Park
    University of Missouri Kansas City, Department of Medicine and Cardiovascular Research Department, Mid America Heart Institute, Saint Luke s Hospital, 64111, USA
    Lipids 36:115-20. 2001
  3. ncbi Mean platelet volume as an indicator of platelet activation: methodological issues
    Yongsoon Park
    Department of Medicine, University of Missouri Kansas City, Kansas City, MO 64108, USA
    Platelets 13:301-6. 2002
  4. ncbi Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids
    Yongsoon Park
    Lipid and Diabetes Research Center, Saint Luke's Hospital, and The University of Missouri-Kansas City School of Medicine, 64111, USA
    Am J Clin Nutr 80:45-50. 2004
  5. ncbi Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance
    Yongsoon Park
    Department of Medicine, University of Missouri, Kansas City, MO 64108, USA
    J Lipid Res 44:455-63. 2003
  6. ncbi EPA, but not DHA, decreases mean platelet volume in normal subjects
    Yongsoon Park
    Department of Medicine, University of Missouri-Kansas City, Missouri 64108, USA
    Lipids 37:941-6. 2002
  7. ncbi Cardiovascular disease and long-chain omega-3 fatty acids
    William S Harris
    Lipid and Diabetes Research Center, Saint Luke s Hospital, University of Missouri Kansas City School of Medicine, 64111, USA
    Curr Opin Lipidol 14:9-14. 2003

Detail Information

Publications7

  1. ncbi A new method for the study of chylomicron kinetics in vivo
    Y Park
    Department of Medicine, University of Missouri Kansas City, St Luke s Hospital, Kansas City, Missouri 64111, USA
    Am J Physiol Endocrinol Metab 279:E1258-63. 2000
    ..kg(-1). h(-1), equal to the presumed ingestion rate. In summary, a radiolabeled intravenous lipid emulsion is able to accurately estimate chylomicron TG R(a) and therefore can be used to measure in vivo fat absorption rates...
  2. ncbi Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion
    Y Park
    University of Missouri Kansas City, Department of Medicine and Cardiovascular Research Department, Mid America Heart Institute, Saint Luke s Hospital, 64111, USA
    Lipids 36:115-20. 2001
    ..The results indicate that a radiolabeled commercial lipid emulsion is metabolized in a fashion similar to native chylomicron TG, and thus can be used to study chylomicron TG kinetics...
  3. ncbi Mean platelet volume as an indicator of platelet activation: methodological issues
    Yongsoon Park
    Department of Medicine, University of Missouri Kansas City, Kansas City, MO 64108, USA
    Platelets 13:301-6. 2002
    ..Mean platelet volume (MPV) is increased in patients at high risk for athero-thrombotic diseases. Thus, an elevated MPV may be a risk marker for platelet activation...
  4. ncbi Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids
    Yongsoon Park
    Lipid and Diabetes Research Center, Saint Luke's Hospital, and The University of Missouri-Kansas City School of Medicine, 64111, USA
    Am J Clin Nutr 80:45-50. 2004
    ..The increases in MVs with EPA and DHA supplementation suggest that these fatty acids may increase the amount of endothelial-bound LpL or its affinity for TRL...
  5. ncbi Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance
    Yongsoon Park
    Department of Medicine, University of Missouri, Kansas City, MO 64108, USA
    J Lipid Res 44:455-63. 2003
    ..The results suggest that omega-3 FA supplementation accelerates chylomicron TG clearance by increasing LPL activity, and that EPA and DHA are equally effective...
  6. ncbi EPA, but not DHA, decreases mean platelet volume in normal subjects
    Yongsoon Park
    Department of Medicine, University of Missouri-Kansas City, Missouri 64108, USA
    Lipids 37:941-6. 2002
    ..4 +/- 0.2 vs. 4.1 +/- 0.5%) and DPA (2.0 +/- 0.4 vs. 3.0 +/- 0.4%) concentrations, but not EPA. In conclusion, EPA, but not DHA, reduces platelet activation, an early step in platelet aggregation...
  7. ncbi Cardiovascular disease and long-chain omega-3 fatty acids
    William S Harris
    Lipid and Diabetes Research Center, Saint Luke s Hospital, University of Missouri Kansas City School of Medicine, 64111, USA
    Curr Opin Lipidol 14:9-14. 2003
    ..Of all known dietary factors, long-chain omega-3 fatty acids may be the most protective against death from coronary heart disease. New evidence has confirmed and refined the cardioprotective role of these fatty acids...